ONPATTRO (patisiran sodium) Alnylam pharms inc Patent: 9,943,538 Expiration: Nov 4, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for…
Drug Patent Expirations for the Week of October 29, 2023 Read Post »
Annual Drug Patent Expirations for VALTOCO Valtoco is a drug marketed by Neurelis Inc and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Neurelis Inc drug VALTOCO appeared first on DrugPatentW…
Annual Drug Patent Expirations for KYPROLIS Kyprolis is a drug marketed by Onyx Pharms Amgen and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent for Onyx Pharms drug KYPROLIS appeared first on DrugPatent…
This chart shows the pharmaceutical companies with the most patents in Costa Rica. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Costa Rica? Read Post »
Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent for Astrazeneca drug CALQUENCE appeared fir…
Annual Drug Patent Expirations for KONVOMEP Konvomep is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Azurity drug KONVOMEP appeared first on DrugPa…
Annual Drug Patent Expirations for TERLIVAZ Terlivaz is a drug marketed by Mallinckrodt Ireland and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Mallinckrodt Ireland drug TERLIVAZ appeare…
New patent for Mallinckrodt Ireland drug TERLIVAZ Read Post »
Annual Drug Patent Expirations for OZURDEX Ozurdex is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent expiration for Abbvie drug OZURDEX appeared first on …
This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug p…
Which pharmaceutical companies have the most drug patents in Luxembourg? Read Post »
Annual Drug Patent Expirations for CALQUENCE Calquence is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eight patents protecting…
The post New patent for Astrazeneca drug CALQUENCE appeared fir…
Get new actionable insights and updates from BiotechBlog
